Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (870)
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$11.70
Total Value
$11.70K
Shares Held After
8,450
% of Holdings
11.8%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$40.14
Total Value
$1.00M
Shares Held After
1,466,934
% of Holdings
1.7%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
43,375
Price
$40.14
Total Value
$1.74M
Shares Held After
353,356
% of Holdings
10.9%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
86,971
Price
$40.14
Total Value
$3.49M
Shares Held After
396,731
% of Holdings
18.0%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
9,044
Price
$40.14
Total Value
$363.03K
Shares Held After
396,731
% of Holdings
2.2%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$96.90
Total Value
$193.80K
Shares Held After
0
% of Holdings
100.0%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
799
Price
$58.11
Total Value
$46.43K
Shares Held After
24,040
% of Holdings
3.2%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
3,618
Price
$57.21
Total Value
$206.99K
Shares Held After
24,839
% of Holdings
12.7%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
2,623
Price
$56.27
Total Value
$147.59K
Shares Held After
28,457
% of Holdings
8.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.61
Total Value
$278.47K
Shares Held After
412,498
% of Holdings
4.4%
DEXCOM INC (DXCM)
Brown Michael Jon — EVP, Chief Legal Officer
Shares
1,700
Price
$63.04
Total Value
$107.17K
Shares Held After
111,204
% of Holdings
1.5%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
235,863
Price
$44.64
Total Value
$10.53M
Shares Held After
3,247,025
% of Holdings
6.8%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
235,863
Price
$44.64
Total Value
$10.53M
Shares Held After
3,247,025
% of Holdings
6.8%
GILEAD SCIENCES, INC. (GILD)
Dickinson Andrew D — Chief Financial Officer
Shares
3,000
Price
$140.96
Total Value
$422.88K
Shares Held After
176,191
% of Holdings
1.7%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm & Corp Aff Officer
Shares
3,000
Price
$140.96
Total Value
$422.88K
Shares Held After
128,779
% of Holdings
2.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
385
Price
$90.10
Total Value
$34.69K
Shares Held After
674,956
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,750
Price
$90.10
Total Value
$247.77K
Shares Held After
3,899,917
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,200
Price
$89.95
Total Value
$197.89K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,300
Price
$90.00
Total Value
$117.00K
Shares Held After
61,202
% of Holdings
2.1%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
15,000
Price
$20.04
Total Value
$300.67K
Shares Held After
349,786
% of Holdings
4.1%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
17,473
Price
$5.00
Total Value
$87.40K
Shares Held After
3,646,967
% of Holdings
0.5%
Simulations Plus, Inc. (SLP)
DiBella John Anthony II — Chief Revenue Officer
Shares
1,000
Price
$13.37
Total Value
$13.37K
Shares Held After
89,140
% of Holdings
1.1%
BRUKER CORP (BRKR)
Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Shares
2,000
Price
$39.90
Total Value
$79.80K
Shares Held After
128,443
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
4
Price
$171.19
Total Value
$684.76
Shares Held After
15,666
% of Holdings
0.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
8
Price
$170.76
Total Value
$1.37K
Shares Held After
15,670
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
68
Price
$169.15
Total Value
$11.50K
Shares Held After
15,678
% of Holdings
0.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
537
Price
$168.64
Total Value
$90.56K
Shares Held After
15,746
% of Holdings
3.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
383
Price
$167.58
Total Value
$64.18K
Shares Held After
16,283
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
327
Price
$584.24
Total Value
$191.05K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
202
Price
$583.41
Total Value
$117.85K
Shares Held After
40,840
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,624
Price
$582.05
Total Value
$945.25K
Shares Held After
41,042
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,819
Price
$581.05
Total Value
$1.64M
Shares Held After
42,666
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,255
Price
$580.02
Total Value
$1.31M
Shares Held After
45,485
% of Holdings
4.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
684
Price
$579.14
Total Value
$396.13K
Shares Held After
47,740
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
629
Price
$577.81
Total Value
$363.44K
Shares Held After
48,424
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$576.98
Total Value
$507.74K
Shares Held After
49,053
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$575.29
Total Value
$46.02K
Shares Held After
49,933
% of Holdings
0.2%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
92,554
Price
$0.76
Total Value
$70.34K
Shares Held After
197,052
% of Holdings
47.0%
Vivani Medical, Inc. (VANI)
Williams Gregg — Director
Shares
1,587,301
Price
$1.26
Total Value
$2.00M
Shares Held After
32,944,484
% of Holdings
4.8%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
1,018
Price
$42.61
Total Value
$43.38K
Shares Held After
111,473
% of Holdings
0.9%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
1,014
Price
$42.61
Total Value
$43.21K
Shares Held After
116,899
% of Holdings
0.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$27.66
Total Value
$175.59K
Shares Held After
69,792
% of Holdings
8.3%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
1,559
Price
$42.53
Total Value
$66.30K
Shares Held After
105,211
% of Holdings
1.5%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
5,226
Price
$41.62
Total Value
$217.51K
Shares Held After
106,770
% of Holdings
4.7%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
20
Price
$42.66
Total Value
$853.20
Shares Held After
432,886
% of Holdings
0.0%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
7,165
Price
$41.75
Total Value
$299.14K
Shares Held After
432,906
% of Holdings
1.6%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
56,815
Price
$41.01
Total Value
$2.33M
Shares Held After
440,071
% of Holdings
11.4%
Alignment Healthcare, Inc. (ALHC)
Maroney Dawn Christine — President
Shares
30,000
Price
$20.87
Total Value
$626.20K
Shares Held After
1,028,813
% of Holdings
2.8%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
500
Price
$67.38
Total Value
$33.69K
Shares Held After
33,377
% of Holdings
1.5%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,273
Price
$66.56
Total Value
$151.30K
Shares Held After
33,877
% of Holdings
6.3%
Showing 101–150 of 870 transactions (page 3 of 18)